Axial Myoclonus in a Patient with PSP
Objective: This is a case report from the Portland VA Medical Center. Background: PSP is a parkinsonian neurodegenerative disorder characterized by deposition of tau in…Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy
Objective: To evaluate the sensitivity and specificity of a radiographic marker, midbrain to pons ratio, in brain MRI of Progressive Supranuclear Palsy (PSP) patients as…Metabolomics study in a group of Parkinson’s disease patients from Northern India
Objective: To do (1) H NMR study in a group of Parkinson’s disease patients, disease controls, viz. multiple system atrophy (MSA) and progressive supra nuclear…Longitudinal AV-1451 PET imaging in Progressive Supranuclear Palsy and Cortico-Basal Syndrome
Objective: To evaluate change in AV-1451 positron emission tomography (PET) imaging in patients with Progressive Supranuclear Palsy (PSP) and Cortico-Basal Syndrome (CBS) over 9 months…Progression of milestones by clinical types in progressive supranuclear palsy: a longitudinal observational study of a cohort of patients with PSP/CBD (the JALPAC project)
Objective: To elucidate the natural history of the PSP clinical phenotype Background: Recently, various clinical types of PSP have been reported, but details on their…Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy
Objective: To compare the features of urinary dysfunction in Progressive supranuclear palsy (PSP) with those of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Background:…Blink reflex recovery cycle to differentiate Progressive Supranuclear Palsy from Corticobasal Degeneration
Objective: To evaluate R2 Blink Reflex Recovery Cycle (BRRC) in patients with Progressive Supranuclear Palsy (PSP) and CorticoBasal Degeneration (CBD) and to determine its diagnostic…Brain metabolic patterns in progressive supranuclear palsy phenotypes
Objective: To describe changes in cerebral glucose metabolism in patients with different described clinical phenotypes of PSP and to correlate them with the clinical manifestations of the disease. Background:…Neuropsychiatric and Cognitive Predictors of Early Diagnosis of Progressive Supranuclear Palsy
Objective: To define differences of neuropsychiatric and neuropsychological profile among Progressive Supranuclear Palsy (PSP) -Richardson syndrome (PSP-RS), PSP-parkinsonism (PSP-P), and Parkinson’s disease (PD), in order…Gait and Cognition in Progressive Supranuclear Palsy: A Significant Association
Objective: In this study we explored the association between gait parameters and cognitive function of PSP. Background: Gait and cognition are interrelated in patients with…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 42
- Next Page »